Heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin, identified by the CAS number 196398-66-0, is a modified form of β-cyclodextrin, a cyclic oligosaccharide composed of seven glucose units. This compound features multiple functional groups, including acetyl and sulfo groups, which enhance its solubility and reactivity in various solvents. The acetylation at the 2 and 3 positions, along with sulfonation at the 6 position, contributes to its ability to form inclusion complexes with a variety of guest molecules, making it useful in drug delivery systems and as a stabilizing agent in pharmaceutical formulations. The presence of sulfo groups imparts anionic characteristics, which can influence its interactions with other charged species in solution. Additionally, the structural modifications can affect its molecular weight, solubility, and overall stability, making it a versatile compound in both research and industrial applications. Its unique properties allow for enhanced bioavailability of encapsulated drugs and improved performance in various chemical processes.

HEPTAKIS(2 3-DI-O-ACETYL-6-O-SULFO)-(B)&

196398-66-0: Heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin, identified by the CAS number 196398-66-0, is a modified form of β-cyclodextrin, a cyclic oligosaccharide composed of seven glucose units. This compound features multiple functional groups, including acetyl and sulfo groups, which enhance its solubility and reactivity in various solvents. The acetylation at the 2 and 3 positions, along with sulfonation at the 6 position, contributes to its ability to form inclusion complexes with a variety of guest molecules, making it useful in drug delivery systems and as a stabilizing agent in pharmaceutical formulations. The presence of sulfo groups imparts anionic characteristics, which can influence its interactions with other charged species in solution. Additionally, the structural modifications can affect its molecular weight, solubility, and overall stability, making it a versatile compound in both research and industrial applications. Its unique properties allow for enhanced bioavailability of encapsulated drugs and improved performance in various chemical processes.

Heptakis(2,3-di-O-acetyl-6-sulfo)-β-cyclodextrin sodium salt

CAS 196398-66-0

HEPTAKIS(2 3-DI-O-ACETYL-6-O-SULFO)-(B)&

Heptakis(2,3-di-O-acetyl-6-sulfo)-β-cyclodextrin sodium salt

Ref: 54-BICY1031

Heptakis(2,3-diacetyl-6-sulfato)-β-cyclodextrin Sodium Salt

Ref: TR-H281118